Adimmune Corporation   Report issue

For profit Phase 2 Phase 4
Founded: Taichung City Taiwan (1965)
Status: No NME R&D (1965)

Organization Overview

First Clinical Trial
2009
NCT01003145
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Adimmune Corporation